HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
Summary by TBNweekly
42 Articles
42 Articles
All
Left
3
Center
11
Right
4

+41 Reposted by 41 other sources
HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Program at FOCIS 2025
BOSTON, June 25, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting Smart Allostery platform-identified regulatory sites on proteins referred to as "natural hotspots," today announced the presentation…
Coverage Details
Total News Sources42
Leaning Left3Leaning Right4Center11Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 17%
C 61%
R 22%
Factuality
To view factuality data please Upgrade to Premium